Introduction
Brucellosis is consistently ranked among the most economically important zoonoses globally (11, 27, 28, 37) . It is a 'multiple burdens' disease with economic impacts attributable to human, livestock and wildlife disease. The epidemiology and economic impact of brucellosis vary by geography and livestock system. In many high-income countries, brucellosis has been successfully controlled or eliminated in livestock populations. Where it persists, wildlife populations have become the main reservoirs (for example, bison and elk in North America). In emerging middle-income countries, the brucellosis picture is much more variable. Middle-income countries tend to report the greatest number of outbreaks and animal losses (see 36) . Economic impacts vary depending on the main livestock species, management systems, and on the capacity of the country' s veterinary and medical systems. In low-income countries, brucellosis is endemic and neglected, with large disease and livelihood burdens in animals and people and almost no effective control (15, 21, 28) .
This article provides an overview of the burden and economic impact of brucellosis in animal and human populations and economic considerations for the prevention and control of brucellosis. While examples and approaches are drawn from different countries, the focus is on endemic brucellosis in the low-income countries of tropical Africa and Asia. These regions are characterised by large numbers of poor livestock keepers in both extensive (often pastoral and semi-pastoral) and intensifying smallholder livestock systems.
This assessment of the economic aspects of brucellosis, with emphasis on the low-income countries of Africa and Asia, is structured in three main parts. The fi rst describes an overall framework for economic assessment of disease burdens and the impacts of potential control programmes. The second part systematically reviews available animal, human and joint burden estimates from studies conducted in these regions. The third section provides estimates, when available, of different costs associated with brucellosis illness and its control. This section also comments on tools and approaches for assessing control programmes that are of particular relevance to low and middle-income countries. The paper will conclude with some general recommendations for economic assessments and decisionmaking for control of brucellosis and other zoonoses.
Framework for the economic assessment of brucellosis
Endemic brucellosis in low-income countries of sub-Saharan Africa and South Asia has multiple economic implications across agriculture and public health and broader economic and social development sectors. Efforts to control the disease in low-income countries must take a different approach. Simply replicating past successes in brucellosis control and eradication in high-income countries will not work.
Low-income countries have at least a ten-fold higher burden of infectious diseases from a wide variety of pathogens (16) . Given the close relationship between people and animals, zoonoses and other animal-associated foodborne diseases are particularly important. In most low-income countries, there is much less public investment in veterinary and health services, with weaker surveillance and operational capacity. On the positive side, increasing access to new technologies and more sophisticated tools for surveillance and targeting responses offer opportunities for improved disease control.
Economically, low-income countries of both South Asia and sub-Saharan Africa are growing relatively rapidly (5%-10% increase in gross domestic product annually), much more so than global averages, although from a much lower base. Government decision-making focuses on economic growth and employment, and any investment arguments for control programmes need to highlight economic returns. This can sometimes be a problem for animal disease control because in low-income countries the monetary value of animals and animal products is much lower than in highincome countries. Similarly, the indirect impacts of diseases on other economic sectors, such as tourism, are much smaller in developing countries than in developed countries (consider the massive indirect costs of the foot and mouth disease outbreak in the United Kingdom in 2002). In low-income countries, economic growth is very unevenly distributed. There is much faster growth in urban areas and rural areas connected by markets to towns and cities. Disconnected and remote areas have been left behind. In more dynamic areas, economic growth is refl ected in improvements in private provision of health and veterinary services and opportunities for mixed public-private service provision.
Invariably, the epidemiological and economic assessments of the different forms of brucellosis in ruminants highlight the importance of controlling the disease in the animal reservoir. In low-income countries, both opportunities and strategies for brucellosis control will vary by livestock production system. In South Asia and sub-Saharan Africa, they vary between the two extremes of the intensifi cation gradient of livestock production systems in which brucellosis is important: intensifying smallholder dairy systems and extensive pastoral and semi-pastoral systems.
Given this context, the authors have developed a framework for the economic assessment of brucellosis in low-income countries (Fig. 1) . The basic building blocks are (i) information on the burden of brucellosis in different systems and (ii) details of the epidemiology and transmission dynamics of the disease. Obtaining this information enables us to understand how this burden might change under different control options (9) . A second level of economic assessment is to look at the sector-specifi c impacts of brucellosis and its control to engage livestock and public health administrators. A third level is then to look at the potential for integrated programme-impact analysis, given the double or triple benefi ts of brucellosis control on animal populations, human populations and the overall economy. Very few of these analyses have been done for any zoonotic disease. The best documented example for brucellosis is the work of Roth, Zinsstag and colleagues in the extensive livestock system of Mongolia (31, 40) . Finally, to engage policy-makers and investors effectively, it is important to assess the overall impacts at different levels of economic interest from households through market chains, and up to national and regional economies.
The burdens of endemic brucellosis in animal and human populations
This section focuses on the upper part of the framework, the estimation of the burden of brucellosis in animals and humans. Historically, estimates of the prevalence and other burden estimates of brucellosis have been relatively rare from tropical Africa and Asia as compared to temperate regions of Asia and Europe. In addition, when disease does occur it is rarely offi cially reported. The World Livestock Disease Atlas (36) , based on offi cial reports to the World Organisation for Animal Health (OIE), has few data from tropical Africa and Asia and does not show these as the highest-risk countries. However, it is clear that the degree of under-reporting of brucellosis is enormous. Even the most conservative prevalence estimates (calculated on the basis of the number of ruminants in Asia and Africa [ Table I ]) suggest that the number of cases is far higher than reported. The results on prevalence and trends in brucellosis presented here were part of a larger review of the impact of 13 of the most important zoonoses in South and SouthEast Asia and Africa (11) . Abstracts of recent articles were searched through PubMed (www.ncbi.nlm.nih.gov/ pubmed/), CABDIRECT (www.cabdirect.org/) and Google (www.google.co.ke/) (including Google Scholar).
Burden in animal populations
From this review (additional details of methods in 11), the authors created a database that included: -the country where the study was done or where the results apply -geo-spatial location (the specifi c location or coordinates, if given) -number of herds studied -number of samples analysed -the specifi c diagnostic test(s) done -subjects (livestock species, food, humans) -individual prevalence -herd prevalence -the year the data were collected -a description of the study population.
Where multiple surveys were reported in one study, each survey was listed separately (e.g. if prevalence was estimated in cattle and sheep, these were considered as two different surveys, each with an associated sample size, species and prevalence). The authors distinguish between 'community studies', which are conducted in the community and can be considered representative of it, and 'high-risk studies', which are conducted in high-risk populations (sick people in hospitals, malnourished children, cattle which failed antemortem inspection, samples taken during an outbreak, etc.).
In total, 259 studies were assessed covering 476,067 animals (244 studies) and 31,842 people (13 studies) and 537 food samples (two studies). Eleven studies were from high-risk groups (mainly people in hospitals) and 248 were from communities. Of the Prevalence % 244 studies in which animals were tested, most (193) were on bovine brucellosis (mostly caused by B. abortus, although B. melitensis is becoming more important), 35 studies were on sheep or goat brucellosis (B. melitensis), and the other 16 studies were on brucellosis in camels, swine and other animal species. Commonly used tests for brucellosis in these studies detect antibodies produced in response to infection. A combination of tests may be used to improve accuracy or ability to detect. Given the endemic nature of brucellosis, positive test results are strongly correlated with infection burden. Depending on the sensitivity and specifi city of individual and combined testing regimes, and the true prevalence of disease within a country, test results may underor over-estimate the true prevalence but usually provide a rough guide. In community surveys, the average prevalence was 13% (0-88.8%) in sheep and goats, 13% (0-68.8%) in bovines, 7% (0.4-20%) in camels, and 5% (0-12.9%) in other species (pigs, dogs). Only three studies (1%) found no evidence of brucellosis, but 33% reported low prevalences greater than zero but less than 5%. The results from this review were then used to map the prevalence of bovine (Fig. 2) , caprine/ovine (Fig. 3) , camel ( Fig. 3 ) and human brucellosis (Fig. 4) by livestock production systems in tropical Asia and Africa.
These results provide strong evidence that brucellosis is a major problem in low-income countries. This is consistent with a previous review for sub-Saharan Africa (15) and not unexpected, given the overall higher burden of infectious diseases in tropical Asia and Africa. Regarding epidemiology, increasing intensifi cation of small and medium-sized livestock enterprises in which livestock movement is relatively uncontrolled is associated with increasing prevalence owing to increased livestock density and contact rates. Brucellosis in traditional pasture-based systems is important and relatively stable. However, higher prevalences are seen in some pastoral systems around wildlife reserves with increased livestock Higher productivity losses are associated with higher prevalence. Seropositive animals have higher rates of abortion, stillbirth, infertility and calf mortality, as well as reduced growth and longer calving intervals. Often, infected females will abort only once, although they may remain infected their entire life. Long-standing infections can result in arthritis and hygromas (a useful marker for brucellosis at herd level).
Older literature in high-income countries found that aborting cows kept for milking produced 20% to 25% less milk for that season, while seropositive non-aborting cows produced 10% below potential (summarised in 11). Several studies in Africa have shown an association between seropositivity and abortions: around one fi fth of cows may abort where seroprevalence is high (>30%) compared to less than 5% of cows in low-prevalence (<5%) areas or nonaffected herds (24, 35) . However, the impacts of brucellosis infections are less marked when overall production is low (7, 18) .
Studies on the economic production losses of bovine brucellosis are reasonably consistent across a range of production systems in Africa, with losses estimated at 6% to 10% of the income per animal (3, 7, 21 as is frequently found when B. abortus is established (2) . Brucellosis in pigs has productivity and economic impacts but there is little information on their magnitude in lowincome countries.
The authors' review included 13 studies in human populations. Several studies in vulnerable populations found high seroprevalences: an average of 11% among livestock keepers/abattoir workers, and 7% among suspect hospital patients. One large study in India found that 2% of patients in the general hospital population tested positive for brucellosis (22) . As in other regions, the main risks for people are occupational (contact with livestock) and consumption of dairy products. Economic losses caused by the disease in humans are a consequence of the cost of hospital treatment, cost of drugs, patient out-of-pocket treatment expenses, and loss of work or income due to illness. In Spain, losses from hospital costs and lost pay were estimated at 787.92 pesetas per patient (5), while estimated costs per case in New Zealand were NZ$3,181 (33).
Broader human disability-adjusted life year (DALY) burdens for brucellosis are yet to be estimated globally or across lowincome countries (38) . This refl ects the fact that human brucellosis is even more under-reported than animal brucellosis. It usually presents as an acute febrile illness, often mistaken for malaria or typhoid (see Ref. 19 as an example, with further references in 15). There is a great need to introduce earlier differential diagnosis for brucellosis in high-risk populations (20) . Chronic complications are not uncommon when diagnosis is delayed.
Economics of control and estimating control programme impacts
Multiple costs (and benefi ts) of brucellosis and its control
As described in the earlier section on the framework for economic assessment, endemic brucellosis in low-income countries has a range of economic implications. The technical and economic feasibility of different control options with different assumptions requires estimation of all potential costs. Figure 5 provides an overall costing framework that considers costs of illness, costs of prevention, and opportunity costs (both public and private) at household, livestock sector, health sector and broader societal levels. included in health metrics (DALYs), *a number of costs (for example, vaccination) produce benefi ts for both the private sector (better livestock production) and the public sector (fewer human infections) DALYs: disability-adjusted life years
Fig. 5
Costs to be considered and estimated in planning brucellosis control and eradication programmes costs of illness and prevention in animals and people. It was the combination of individual and joint benefi ts that made brucellosis control attractive to government decisionmakers. Shepherd et al. (33) used government budget numbers to estimate programme costs over a 10-year period (both veterinary and public health). Disease losses in the animal sectors were estimated using market prices. In addition to DALY estimates, direct and indirect costs were estimated through a survey, including opportunity costs of non-agricultural labour and care. Another example of detailed costing of healthcare is the costing undertaken by Kaufmann et al. as part of their estimation of the costs of responding to the deliberate introduction of brucellosis by bio-terrorism (13).
In low-income countries, it is essential to include all potential benefi ts of brucellosis control in economic assessments. For example, in the Mongolia study carried out by Roth et al., reduced public health department costs provided only 11% of the overall benefi ts (39) . However, when adjusted for livestock-sector benefi ts and other hospital and healthcare benefi ts, the cost per DALY averted was estimated at US$19.1. As a rule of thumb, interventions that cost less than US$150 per DALY averted are 'attractive' from a public health perspective, while those that cost US$25 per DALY averted are 'highly attractive' (39) .
A key challenge in economic estimation of the feasibility of proposed control programmes, and of the possible returns on investment, is to have a credible ex ante analysis using two or three different scenarios (see, for example 4, 33). Depending on the main burdens to be prevented, cost-effectiveness analysis (if human health impacts are important) or cost-benefi t analysis (if only livestock-sector benefi ts are needed to justify control) can be undertaken. In the Mongolia study, given the importance of livestock-sector benefi ts, much care was taken in their ex ante estimation. Key parameters were estimated from the literature and expert opinion was used in a herd dynamic and productivity model (see 40) . When joint animal and human costs and benefi ts of control are being estimated, modifi ed cost-effectiveness analysis is the standard approach (31) . In analyses limited to livestock-sector costs and benefi ts, classical cost-benefi t analysis can be done (4). As will be highlighted in the next section, appropriate and rigorous ex ante analysis of potential control costs and benefi ts is usually not done, or if done, key elements and potential problems are ignored, providing overly optimistic projections.
Options for and experiences of endemic brucellosis control in low-and middle-income countries
Most successful efforts to control, and in many cases eradicate, brucellosis have been in high-and middleincome countries (and one low-income country -Nigeria) (see Table II ). In general, successful control (and usually elimination in the livestock population) has led to positive benefi t-cost ratios (even when public health benefi ts and the additional longer-term benefi ts of reducing control costs are not taken into account). The general pattern of control has been to establish a diagnostic and surveillance system and estimate the prevalence and distribution of brucellosis. From this diagnostic base, initial control measures, including vaccination, may be implemented to reduce an initial high prevalence. From there, testing, quarantine and slaughter with compensation policies are established. Sometimes special measures are required in late stages for high-risk populations. Often, the fi nal stages are most diffi cult, when prevalence rates are low and the cost of fi nding the fi nal positive animals is very high. The principles for these control and eradication programmes can be found in standard reference materials (6) . Complications arise in eradication programmes if wildlife reservoirs exist. These are the topic of other papers in this volume.
However, attempts to control and eradicate brucellosis in middle-income countries using these classical approaches have been much less successful. These include the attempt to control brucellosis in Mongolia, which progressed at a very slow pace, as well as less than successful control programmes in Egypt, Israel (B. melitensis), Macedonia, India and the Azores (8, 23) . Disease control and eradication are either probably not feasible or probably not economically viable in countries with inadequate veterinary resources, an inability to control livestock movement, widespread brucellosis in feral animals or wildlife, and farmers who are not strongly committed to public disease control efforts. These factors are often not considered in superfi cial ex ante economic analyses and ignoring these provides an investment picture that does not refl ect reality.
In low-and middle-income countries, more targeted control measures may be more realistic and useful. Reduction of prevalence through targeted and time-bound vaccination campaigns may be economically benefi cial as it could stop the spread of an outbreak of B. melitensis. Such an approach is reported to have been successful in Tunisia and Morocco (2) . In slower-moving, more endemic situations, treatment can successfully eliminate shedding of organisms from long-term carriers (29) , but it is believed to be economically unviable. Likewise, more targeted efforts at diagnosis, and treatment of occupational and other higher-risk human populations, will be more cost-effective than trying to implement human diagnosis and treatment programmes more generally.
For most of these more targeted control approaches, there is some information available on the success and failure factors, but very little on economic costs and benefi ts. Clearly, larger national control programmes will need to be justifi ed through estimates of the longer-term economic benefi ts that accrue when eradication is achieved. In addition, long-term control without eradication is very diffi cult to maintain. Thus, for most low-income countries, more targeted control interventions will be the initial approach.
Conclusions and future approaches
In general, there is reasonable evidence that the overall burden of brucellosis in animal and human populations in low-income countries of tropical Asia and Africa is large. The challenge is to establish the evidence required to appropriately plan and economically assess more targeted control efforts that might be feasible and economically benefi cial. From the evidence to date, there are a few main lessons and indications for future strategic control. The fi rst is that national control programmes in lowincome countries are unlikely to succeed when national Veterinary Services are weak and livestock movements are uncontrolled. In such cases, targeted efforts are much more likely to be technically feasible and economically justifi able. Such efforts might include vaccination when B. melitensis outbreaks are starting, or vaccination in high-prevalence populations which have potential for high productivity. To reduce human burdens, improving diagnosis and treatment in high-risk populations, and improving control along the food value chains when possible (for example, boiling milk), are both examples of potential targeted interventions.
As veterinary capacity and general livestock-sector management improve, economic methods such as those applied in the ex ante assessment of brucellosis control in Mongolia (33, 39, 40) should be applied. It is important to anticipate potential logistical problems and to deploy resources and invest quickly to establish and maintain momentum, as speed is critical to success.
Given the importance of endemic as well as emerging zoonoses to economic development and public health, 'One Health' risk-management frameworks for veterinary and veterinary public health will have broader benefi ts. A proposed framework has been provided (25) . The approach is to build capacity and improve epidemiological and economic decision-making and to effectively communicate risk assessment results and risk management practices to maximise the uptake and rapid adaptation of control interventions. The delivery of such benefi cial public systems could be through a combination of public and private service providers (17) . There is an urgent need to build these capacities, as livestock systems are intensifying due to rapid increases in demand for livestock products in low-and middle-income countries. Resumen La mayoría de los datos y las pruebas sobre la carga económica de la brucelosis y los benefi cios derivados de su control proceden de países de ingresos altos y medianos, pero en cambio la carga que supone la brucelosis alcanza sus máximas cotas en los países de bajo nivel de renta. Los autores se centran en la estimación de la carga económica de la brucelosis en los países de ingresos bajos de la franja tropical de Asia y África. En la mayoría de esos países hay escasas perspectivas de poder instaurar programas nacionales de control de la brucelosis técnicamente factibles y económicamente viables. Sin embargo, hay ciertos programas de lucha de carácter selectivo que serían benefi ciosos, de gestión seguramente factible y económicamente rentables. En cambio, la aplicación de programas de control más ambiciosos exige potenciar de modo más general la capacidad de los Servicios Veterinarios y el sector ganadero aplicando planteamientos basados en la gestión del riesgo.
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